{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:16:48Z","timestamp":1794435408277,"version":"4.9.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004869","name":"Universit\u00e4t M\u00fcnster","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004869","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Alpha-melanocyte-stimulating-hormone (\u03b1-MSH) has been identified as a new anti-inflammatory treatment compound in rheumatoid arthritis (RA) and other inflammatory diseases. However, its direct effect on bone cell differentiation or on bone regeneration, which is an inflammatory process, too, has not been investigated, yet. Bone tissue is significantly affected in inflammatory joint diseases. Additionally, inflammatory signaling is essential -in bone regeneration during fracture healing. Therefore, we evaluated the impact of \u03b1-MSH-treatment on bone forming cells in an inflammatory setting in vitro and as a treatment approach in a murine fracture healing model in vivo.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The influence of \u03b1-MSH treatment and melanocortin-receptor expression patterns was investigated in vitro in the presence of either IL-1\u03b2 or\/and TNF-\u03b1 as an inflammatory stimulus. Osteoblast cell function was evaluated by analyzing proliferation and mineralisation capacities. Using quantitative real time PCR, we analyzed mRNA expression of receptors. To explore the impact of \u03b1-MSH on bone regeneration in vivo, treatment with \u03b1-MSH or NaCl (control) was performed in a murine fracture-healing model using a closed femur fracture stabilized with an intramedullary implant (female, <jats:italic>n<\/jats:italic>\u2009=\u20096\u20138 mice per group).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>\u03b1-MSH-treatment did not impair either proliferation nor mineralisation of osteoblastic cells under native or inflammatory conditions (no significant differences found). All four melanocortin receptor-molecules were expressed in murine osteoblastic cells but in very limited amounts and this did not change upon treatment with inflammatory cytokines or \u03b1-MSH or both at the same time. Callus formation in fractured femurs of \u03b1-MSH-treated mice was slightly delayed at day 14 post fracture with regard to less cartilage formation (NaCl: 19.9%; \u03b1-MSH: 13.5%) and soft tissue remodeling (NaCl: 15.2%; \u03b1-MSH: 19.5%) but these results were not significantly different and fracture healing overall occurred in a regular way.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>\u03b1-MSH has no negative impact on bone or bone-forming cells in native, inflammatory, or regenerative contexts. We can conclude from our results, that treatment of inflammatory diseases using \u03b1-MSH does not interfere significantly with bone regeneration in a murine fracture model and therefore treatment with \u03b1-MSH could be continued without negative effects on bone formation and bone regeneration in patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical trial number<\/jats:title>\n            <jats:p>Not applicable.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12891-025-08374-9","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T08:12:04Z","timestamp":1738829524000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Anti-inflammatory treatment using alpha melanocyte stimulating hormone (\u03b1-MSH) does not alter osteoblasts differentiation and fracture healing"],"prefix":"10.1186","volume":"26","author":[{"given":"Johanna","family":"Graue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Timmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kronenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishor K.","family":"Sivaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Gabriele","family":"Bixel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Stange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"key":"8374_CR1","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/ng1195-328","volume":"11","author":"P Valverde","year":"1995","unstructured":"Valverde P, Healy E, Jackson I, Rees JL, Thody AJ. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet. 1995;11:328\u201330.","journal-title":"Nat Genet"},{"key":"8374_CR2","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/exd.14260","volume":"30","author":"JM Yardman-Frank","year":"2021","unstructured":"Yardman-Frank JM, Fisher DE. Skin pigmentation and its control: from ultraviolet radiation to stem cells. Exp Dermatol. 2021;30:560\u201371.","journal-title":"Exp Dermatol"},{"key":"8374_CR3","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1210\/er.2006-0034","volume":"27","author":"RD Cone","year":"2006","unstructured":"Cone RD. Studies on the physiological functions of the melanocortin system. Endocr Rev. 2006;27:736\u201349.","journal-title":"Endocr Rev"},{"key":"8374_CR4","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1210\/er.2011-1016","volume":"33","author":"M B\u00f6hm","year":"2012","unstructured":"B\u00f6hm M, Gr\u00e4ssel S. Role of proopiomelanocortin-derived peptides and their receptors in the osteoarticular system: from basic to translational research. Endocr Rev. 2012;33:623\u201351.","journal-title":"Endocr Rev"},{"key":"8374_CR5","doi-asserted-by":"crossref","unstructured":"Dinparastisaleh R, Mirsaeidi M. Antifibrotic and anti-inflammatory actions of \u03b1-Melanocytic hormone: New roles for an old player. Pharmaceuticals (Basel Switzerland) 2021;14.","DOI":"10.3390\/ph14010045"},{"key":"8374_CR6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3389\/fendo.2019.00683","volume":"10","author":"W Wang","year":"2019","unstructured":"Wang W, Guo D-Y, Lin Y-J, Tao Y-X. Melanocortin regulation of inflammation. Front Endocrinol. 2019;10:683.","journal-title":"Front Endocrinol"},{"key":"8374_CR7","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1749-6632.2000.tb05388.x","volume":"917","author":"TA Luger","year":"2000","unstructured":"Luger TA, et al. The role of alpha-MSH as a modulator of cutaneous inflammation. Ann N Y Acad Sci. 2000;917:232\u20138.","journal-title":"Ann N Y Acad Sci"},{"key":"8374_CR8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.4049\/jimmunol.171.1.353","volume":"171","author":"U Raap","year":"2003","unstructured":"Raap U, et al. Alpha-melanocyte-stimulating hormone inhibits allergic airway inflammation. J Immunol (Baltimore Md: 1950). 2003;171:353\u20139.","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"8374_CR9","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0196-9781(96)00345-2","volume":"18","author":"N Rajora","year":"1997","unstructured":"Rajora N, Boccoli G, Catania A, Lipton J. M. alpha-MSH modulates experimental inflammatory bowel disease. Peptides. 1997;18:381\u20135.","journal-title":"Peptides"},{"key":"8374_CR10","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1523\/JNEUROSCI.17-06-02181.1997","volume":"17","author":"N Rajora","year":"1997","unstructured":"Rajora N, et al. alpha-MSH modulates local and circulating tumor necrosis factor-alpha in experimental brain inflammation. J Neuroscience: Official J Soc Neurosci. 1997;17:2181\u20136.","journal-title":"J Neuroscience: Official J Soc Neurosci"},{"key":"8374_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000097183","volume":"1","author":"A Catania","year":"1994","unstructured":"Catania A, et al. The anticytokine neuropeptide alpha-melanocyte-stimulating hormone in synovial fluid of patients with rheumatic diseases: comparisons with other anticytokine molecules. Neuroimmunomodulation. 1994;1:321\u20138.","journal-title":"Neuroimmunomodulation"},{"key":"8374_CR12","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1100\/tsw.2009.163","volume":"9","author":"SJ Getting","year":"2009","unstructured":"Getting SJ, et al. Melanocortin peptide therapy for the treatment of arthritic pathologies. TheScientificWorldJournal. 2009;9:1394\u2013414.","journal-title":"TheScientificWorldJournal"},{"key":"8374_CR13","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1002\/art.24846","volume":"60","author":"S Gr\u00e4ssel","year":"2009","unstructured":"Gr\u00e4ssel S, et al. The melanocortin system in articular chondrocytes: melanocortin receptors, pro-opiomelanocortin, precursor proteases, and a regulatory effect of alpha-melanocyte-stimulating hormone on proinflammatory cytokines and extracellular matrix components. Arthritis Rheum. 2009;60:3017\u201327.","journal-title":"Arthritis Rheum"},{"key":"8374_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.bcp.2016.07.003","volume":"116","author":"M B\u00f6hm","year":"2016","unstructured":"B\u00f6hm M, et al. \u03b1-MSH modulates cell adhesion and inflammatory responses of synovial fibroblasts from osteoarthritis patients. Biochem Pharmacol. 2016;116:89\u201399.","journal-title":"Biochem Pharmacol"},{"key":"8374_CR15","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.bone.2005.01.020","volume":"36","author":"Q Zhong","year":"2005","unstructured":"Zhong Q, et al. Multiple melanocortin receptors are expressed in bone cells. Bone. 2005;36:820\u201331.","journal-title":"Bone"},{"key":"8374_CR16","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3349\/ymj.2002.43.4.500","volume":"43","author":"S-K Lim","year":"2002","unstructured":"Lim S-K, et al. The effect of alphaMSH analogues on rat bones. Yonsei Med J. 2002;43:500\u201310.","journal-title":"Yonsei Med J"},{"key":"8374_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2018.11.033","volume":"844","author":"L Wang","year":"2019","unstructured":"Wang L, et al. \u03b1-melanocyte stimulating hormone (\u03b1-MSH) promotes osteoblast differentiation of MC3T3-E1 cells. Eur J Pharmacol. 2019;844:1\u20138.","journal-title":"Eur J Pharmacol"},{"key":"8374_CR18","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1007\/s11033-021-06288-y","volume":"48","author":"S Berardi","year":"2021","unstructured":"Berardi S, Corrado A, Maruotti N, Cici D, Cantatore F. P. osteoblast role in the pathogenesis of rheumatoid arthritis. Mol Biol Rep. 2021;48:2843\u201352.","journal-title":"Mol Biol Rep"},{"key":"8374_CR19","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00223-017-0373-1","volume":"102","author":"J-H Shim","year":"2018","unstructured":"Shim J-H, Stavre Z, Gravallese EM. Bone loss in rheumatoid arthritis: Basic mechanisms and clinical implications. Calcif Tissue Int. 2018;102:533\u201346.","journal-title":"Calcif Tissue Int"},{"key":"8374_CR20","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1007\/s00198-017-4170-5","volume":"28","author":"L Heinlen","year":"2017","unstructured":"Heinlen L, Humphrey MB. Skeletal complications of rheumatoid arthritis. Osteoporos Int. 2017;28:2801\u201312.","journal-title":"Osteoporos Int"},{"key":"8374_CR21","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s43465-020-00117-3","volume":"54","author":"JK Lee","year":"2020","unstructured":"Lee JK, et al. Is femoral fracture Healing really compromised in patients with rheumatoid arthritis? Comparison study between rheumatoid and non-rheumatoid arthritis patients. Indian J Orthop. 2020;54:599\u2013607.","journal-title":"Indian J Orthop"},{"key":"8374_CR22","doi-asserted-by":"publisher","first-page":"e162775","DOI":"10.1001\/jamasurg.2016.2775","volume":"151","author":"R Zura","year":"2016","unstructured":"Zura R, et al. Epidemiology of fracture Nonunion in 18 human bones. JAMA Surg. 2016;151:e162775.","journal-title":"JAMA Surg"},{"key":"8374_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000097087","volume":"1","author":"G Ceriani","year":"1994","unstructured":"Ceriani G, Diaz J, Murphree S, Catania A, Lipton JM. The neuropeptide alpha-melanocyte-stimulating hormone inhibits experimental arthritis in rats. Neuroimmunomodulation. 1994;1:28\u201332.","journal-title":"Neuroimmunomodulation"},{"key":"8374_CR24","doi-asserted-by":"publisher","first-page":"R877","DOI":"10.1152\/ajpregu.00447.2012","volume":"304","author":"AB G\u00f3mez-SanMiguel","year":"2013","unstructured":"G\u00f3mez-SanMiguel AB, et al. Systemic \u03b1-melanocyte-stimulating hormone administration decreases arthritis-induced anorexia and muscle wasting. Am J Physiol Regul Integr Comp Physiol. 2013;304:R877\u201386.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"8374_CR25","first-page":"4835","volume":"24","author":"HB Patel","year":"2010","unstructured":"Patel HB, et al. Anti-inflammatory and antiosteoclastogenesis properties of endogenous melanocortin receptor type 3 in experimental arthritis. FASEB Journal: Official Publication Federation Am Soc Experimental Biology. 2010;24:4835\u201343.","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"},{"key":"8374_CR26","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.4049\/jimmunol.1402645","volume":"194","author":"T Montero-Melendez","year":"2015","unstructured":"Montero-Melendez T, Gobbetti T, Cooray SN, Jonassen TEN, Perretti M. Biased agonism as a novel strategy to harness the proresolving properties of melanocortin receptors without eliciting melanogenic effects. J Immunol. 2015;194:3381\u20138.","journal-title":"J Immunol"},{"key":"8374_CR27","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41467-020-14421-x","volume":"11","author":"T Montero-Melendez","year":"2020","unstructured":"Montero-Melendez T, et al. Therapeutic senescence via GPCR activation in synovial fibroblasts facilitates resolution of arthritis. Nat Commun. 2020;11:745.","journal-title":"Nat Commun"},{"key":"8374_CR28","doi-asserted-by":"publisher","first-page":"172971","DOI":"10.1016\/j.ejphar.2020.172971","volume":"872","author":"VC Can","year":"2020","unstructured":"Can VC, et al. Novel anti-inflammatory and chondroprotective effects of the human melanocortin MC1 receptor agonist BMS-470539 dihydrochloride and human melanocortin MC3 receptor agonist PG-990 on lipopolysaccharide activated chondrocytes. Eur J Pharmacol. 2020;872:172971.","journal-title":"Eur J Pharmacol"},{"key":"8374_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1476-5381.2012.01968.x","volume":"167","author":"MK Kaneva","year":"2012","unstructured":"Kaneva MK, et al. Chondroprotective and anti-inflammatory role of melanocortin peptides in TNF-\u03b1 activated human C-20\/A4 chondrocytes. Br J Pharmacol. 2012;167:67\u201379.","journal-title":"Br J Pharmacol"},{"key":"8374_CR30","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12891-015-0615-1","volume":"16","author":"F Capsoni","year":"2015","unstructured":"Capsoni F, et al. \u03b1-Melanocyte-stimulating-hormone (\u03b1-MSH) modulates human chondrocyte activation induced by proinflammatory cytokines. BMC Musculoskelet Disord. 2015;16:154.","journal-title":"BMC Musculoskelet Disord"},{"key":"8374_CR31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ygcen.2018.03.020","volume":"262","author":"H Ishizu","year":"2018","unstructured":"Ishizu H, et al. \u03b1-Melanocyte-stimulating hormone promotes bone resorption resulting from increased osteoblastic and osteoclastic activities in goldfish. Gen Comp Endocrinol. 2018;262:99\u2013105.","journal-title":"Gen Comp Endocrinol"},{"key":"8374_CR32","doi-asserted-by":"publisher","first-page":"A622","DOI":"10.1136\/annrheumdis-2012-eular.126","volume":"71","author":"J Bertrand","year":"2012","unstructured":"Bertrand J, et al. Bone fracture repair, but not fetal skeletal development is supported by syndecan-4. Ann Rheum Dis. 2012;71:A622\u201363.","journal-title":"Ann Rheum Dis"},{"key":"8374_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00068-004-1322-z","volume":"30","author":"G Schmidmaier","year":"2004","unstructured":"Schmidmaier G, et al. Development and characterization of a standard closed tibial fracture model in the rat. Eur J Trauma. 2004;30:35\u201342.","journal-title":"Eur J Trauma"},{"key":"8374_CR34","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/1471-2474-15-184","volume":"15","author":"M Timmen","year":"2014","unstructured":"Timmen M, et al. Influence of antiTNF-alpha antibody treatment on fracture healing under chronic inflammation. BMC Musculoskelet Disord. 2014;15:184.","journal-title":"BMC Musculoskelet Disord"},{"key":"8374_CR35","doi-asserted-by":"publisher","first-page":"5754","DOI":"10.1073\/pnas.77.10.5754","volume":"77","author":"TK Sawyer","year":"1980","unstructured":"Sawyer TK, et al. 4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity. Proc Natl Acad Sci USA. 1980;77:5754\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8374_CR36","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/j.1476-5381.2010.01098.x","volume":"162","author":"A Bitto","year":"2011","unstructured":"Bitto A, et al. Melanocortins protect against multiple organ dysfunction syndrome in mice. Br J Pharmacol. 2011;162:917\u201328.","journal-title":"Br J Pharmacol"},{"key":"8374_CR37","doi-asserted-by":"publisher","first-page":"362ra146","DOI":"10.1126\/scitranslmed.aaf8732","volume":"8","author":"N Mykicki","year":"2016","unstructured":"Mykicki N, et al. Melanocortin-1 receptor activation is neuroprotective in mouse models of neuroinflammatory disease. Sci Transl Med. 2016;8:362ra146.","journal-title":"Sci Transl Med"},{"key":"8374_CR38","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12974-019-1591-4","volume":"16","author":"X Wu","year":"2019","unstructured":"Wu X, et al. NDP-MSH binding melanocortin-1 receptor ameliorates neuroinflammation and BBB disruption through CREB\/Nr4a1\/NF-\u03baB pathway after intracerebral hemorrhage in mice. J Neuroinflamm. 2019;16:192.","journal-title":"J Neuroinflamm"},{"key":"8374_CR39","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/art.24228","volume":"60","author":"A Kokot","year":"2009","unstructured":"Kokot A, et al. Alpha-melanocyte-stimulating hormone suppresses bleomycin-induced collagen synthesis and reduces tissue fibrosis in a mouse model of scleroderma: melanocortin peptides as a novel treatment strategy for scleroderma? Arthritis Rheum. 2009;60:592\u2013603.","journal-title":"Arthritis Rheum"},{"key":"8374_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/BF02556874","volume":"38","author":"CG Bellows","year":"1986","unstructured":"Bellows CG, Aubin JE, Heersche JN, Antosz ME. Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int. 1986;38:143\u201354.","journal-title":"Calcif Tissue Int"},{"key":"8374_CR41","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/(SICI)1097-4644(19990915)74:4<616::AID-JCB11>3.0.CO;2-Q","volume":"74","author":"L Malaval","year":"1999","unstructured":"Malaval L, Liu F, Roche P, Aubin JE. Kinetics of osteoprogenitor proliferation and osteoblast differentiation in vitro. J Cell Biochem. 1999;74:616\u201327.","journal-title":"J Cell Biochem"},{"key":"8374_CR42","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41586-019-1104-8","volume":"569","author":"AN Tikhonova","year":"2019","unstructured":"Tikhonova AN, et al. The bone marrow microenvironment at single-cell resolution. Nature. 2019;569:222\u20138.","journal-title":"Nature"},{"key":"8374_CR43","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41467-022-28142-w","volume":"13","author":"KK Sivaraj","year":"2022","unstructured":"Sivaraj KK, et al. Mesenchymal stromal cell-derived septoclasts resorb cartilage during developmental ossification and fracture healing. Nat Commun. 2022;13:571.","journal-title":"Nat Commun"},{"key":"8374_CR44","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrrheum.2012.1","volume":"8","author":"L Claes","year":"2012","unstructured":"Claes L, Recknagel S, Ignatius A. Fracture healing under healthy and inflammatory conditions. Nat Rev Rheumatol. 2012;8:133\u201343.","journal-title":"Nat Rev Rheumatol"},{"key":"8374_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41413-021-00150-4","volume":"9","author":"C Wang","year":"2021","unstructured":"Wang C, et al. Targeting angiogenesis for fracture nonunion treatment in inflammatory disease. Bone Res. 2021;9:29.","journal-title":"Bone Res"},{"key":"8374_CR46","doi-asserted-by":"publisher","first-page":"E1181","DOI":"10.1152\/ajpendo.00412.2002","volume":"284","author":"J Cornish","year":"2003","unstructured":"Cornish J, et al. Alpha -melanocyte-stimulating hormone is a novel regulator of bone. Am J Physiol Endocrinol Metab. 2003;284:E1181\u201390.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"8374_CR47","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1089\/scd.2013.0336","volume":"23","author":"LE Sidney","year":"2014","unstructured":"Sidney LE, Kirkham GR, Buttery LD. Comparison of osteogenic differentiation of embryonic stem cells and primary osteoblasts revealed by responses to IL-1\u03b2, TNF-\u03b1, and IFN-\u03b3. Stem Cells Dev. 2014;23:605\u201317.","journal-title":"Stem Cells Dev"},{"key":"8374_CR48","doi-asserted-by":"publisher","first-page":"e7844","DOI":"10.1590\/1414-431x20187844","volume":"52","author":"G Shi","year":"2018","unstructured":"Shi G, et al. Necroptosis occurs in osteoblasts during tumor necrosis factor-\u03b1 stimulation and caspase-8 inhibition. Brazilian J Med Biol Res = Revista brasileira de pesquisas medicas e Biologicas. 2018;52:e7844.","journal-title":"Brazilian J Med Biol Res = Revista brasileira de pesquisas medicas e Biologicas"},{"key":"8374_CR49","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1002\/cbin.11394","volume":"44","author":"L-W Zheng","year":"2020","unstructured":"Zheng L-W, et al. TNF-\u03b1 regulates the early development of avascular necrosis of the femoral head by mediating osteoblast autophagy and apoptosis via the p38 MAPK\/NF-\u03baB signaling pathway. Cell Biol Int. 2020;44:1881\u20139.","journal-title":"Cell Biol Int"},{"key":"8374_CR50","doi-asserted-by":"publisher","first-page":"5445","DOI":"10.1210\/endo.136.12.7588294","volume":"136","author":"M Hukkanen","year":"1995","unstructured":"Hukkanen M, et al. Cytokine-stimulated expression of inducible nitric oxide synthase by mouse, rat, and human osteoblast-like cells and its functional role in osteoblast metabolic activity. Endocrinology. 1995;136:5445\u201353.","journal-title":"Endocrinology"},{"key":"8374_CR51","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.joca.2008.11.011","volume":"17","author":"DC Lacey","year":"2009","unstructured":"Lacey DC, Simmons PJ, Graves SE, Hamilton JA. Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation. Osteoarthr Cartil. 2009;17:735\u201342.","journal-title":"Osteoarthr Cartil"},{"key":"8374_CR52","doi-asserted-by":"crossref","unstructured":"Dumont LM, Wu C-SJ, Tatnell MA, Cornish J, Mountjoy KG. Evidence for direct actions of melanocortin peptides on bone metabolism (2005).","DOI":"10.1016\/j.peptides.2004.12.034"},{"key":"8374_CR53","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1046\/j.1365-2133.1998.02357.x","volume":"139","author":"Y Funasaka","year":"1998","unstructured":"Funasaka Y, et al. Modulation of melanocyte-stimulating hormone receptor expression on normal human melanocytes: evidence for a regulatory role of ultraviolet B, interleukin-1alpha, interleukin-1beta, endothelin-1 and tumour necrosis factor-alpha. Br J Dermatol. 1998;139:216\u201324.","journal-title":"Br J Dermatol"},{"key":"8374_CR54","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/jor.21061","volume":"28","author":"J Lange","year":"2010","unstructured":"Lange J, et al. Action of IL-1beta during fracture healing. J Orthop Research: Official Publication Orthop Res Soc. 2010;28:778\u201384.","journal-title":"J Orthop Research: Official Publication Orthop Res Soc"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-025-08374-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-025-08374-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-025-08374-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T08:43:24Z","timestamp":1738831404000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-025-08374-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8374"],"URL":"https:\/\/doi.org\/10.1186\/s12891-025-08374-9","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]},"assertion":[{"value":"18 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental protocols were approved by the Landesamt f\u00fcr Naturschutz, Umweltschutz und Verbraucherschutz (LANUV, reference numbers: 84-02.04.2014.A434; 84-02.05.50.A15.005), North Rhine-Westphalia, Germany, and performed according to governmental guidelines for the use of experimental animals and as well as the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}